The timing of using IVIG for neonatal ABO hemolytic disease
Regular monitoring of TSB levels starting 24 h after birth is an effective strategy to prevent severe hyperbilirubinemia in ABO HDN. For southwest Chinese neonates, IVIG should not be routinely used to treat ABO HDN in those admitted > 48 h after birth.
Authors
- Bin Xia (ORCID: https://orcid.org/0000-0002-0340-8082)
- Hu Yong
- Feihong Zhang (ORCID: https://orcid.org/0000-0001-5813-523X)
- Na Ma
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1186/s12887-025-06062-0
- Primary Topic
- Neonatal Health and Biochemistry
- Type
- article
- Field-Weighted Citation Impact
- 0.00